tiprankstipranks
Trending News
More News >
Shoe Zone PLC (GB:SHOE)
LSE:SHOE

Shoe Zone (SHOE) AI Stock Analysis

Compare
15 Followers

Top Page

GB:SHOE

Shoe Zone

(LSE:SHOE)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
59.00p
▼(-12.59% Downside)
The score is held back primarily by weakening profitability and a strong bearish technical trend (price below all key moving averages with negative MACD). These are partially offset by comparatively resilient cash generation and a moderate P/E valuation.
Positive Factors
Strong cash generation
Shoe Zone’s materially improved free cash flow (up ~75% to ~£17.1m) and strong operating cash flow provide durable internal funding for capex, inventory and debt servicing. Reliable cash conversion cushions the business through retail cycles and supports strategic flexibility over months.
Improved balance sheet stability
Leverage has normalized to roughly 1.0x debt-to-equity after earlier stress, and equity has rebuilt versus prior years. This materially reduces short-term refinancing risk and gives the company greater resilience to absorb earnings weakness or invest in omnichannel execution over the medium term.
Diversified retail channels
A two-channel model combining an extensive physical store network and e-commerce provides structural customer reach and pricing flexibility. This omnichannel footprint supports scale buying, inventory optimisation and customer acquisition diversification, reducing single-channel dependency over time.
Negative Factors
Revenue decline and margin compression
Top-line contraction and compression to a low net margin (~1.3%) signal reduced earnings power and limited operating leverage. Persistently thin margins weaken the firm’s ability to absorb cost inflation or fund investments, increasing structural vulnerability if sales do not recover sustainably.
Material EPS deterioration
A ~75% decline in EPS reflects sharp earnings volatility and operational stress. Such pronounced EPS deterioration limits retained earnings for reinvestment, heightens reliance on cash management, and constrains strategic options if the trend persists over multiple reporting periods.
Cyclical and seasonal demand exposure
Reliance on seasonal demand and promotional cycles creates structural revenue volatility and margin pressure. Concentrated selling periods increase inventory and working-capital risk, requiring tight merchandising and cash management to avoid markdown-led profit erosion across 2–6 month horizons.

Shoe Zone (SHOE) vs. iShares MSCI United Kingdom ETF (EWC)

Shoe Zone Business Overview & Revenue Model

Company DescriptionShoe Zone plc operates as a footwear retailer in the United Kingdom and the Republic of Ireland. The company offers shoes for men, women, boys, and girls. It operates 410 stores and shoezone.com, a Website. The company was incorporated in 2014 and is based in Leicester, the United Kingdom.
How the Company Makes MoneyShoe Zone generates revenue primarily through the sale of footwear and related accessories in its physical retail stores and via its e-commerce platform. The company operates a low-cost business model, which allows it to offer competitive pricing, thus attracting a broad customer base. Key revenue streams include direct sales from brick-and-mortar locations and online sales, with seasonal promotions and discounts playing a significant role in driving traffic and conversions. Additionally, Shoe Zone may benefit from supplier partnerships and exclusive product lines that enhance its product offerings and customer appeal. The strategic focus on cost-effective operations and an efficient supply chain further supports profitability.

Shoe Zone Financial Statement Overview

Summary
Overall fundamentals are mixed. Income statement trends have deteriorated (revenue down ~4.6% and net margin compressed to ~1.3%), but cash flow is relatively strong (free cash flow ~£17.1m, +75%) and leverage is more manageable than earlier years (debt-to-equity ~1.0).
Income Statement
46
Neutral
Profitability has weakened materially in the latest annual period (2025-09-30): revenue declined (-4.63%) and margins compressed sharply (net margin ~1.3% vs ~4.6% in 2024 and ~8.0% in 2023). The company is still profitable, but earnings power looks meaningfully lower than the prior two years, and the multi-year trend shows a post-2022 normalization from stronger margin levels.
Balance Sheet
60
Neutral
Leverage looks manageable in the most recent year with debt roughly in line with equity (debt-to-equity ~1.0 in 2025), improving significantly from the much higher leverage seen in 2020–2021. Equity has also rebuilt versus earlier periods, supporting balance sheet stability, though the company remains meaningfully levered and would be more exposed if profitability stays at today’s lower level.
Cash Flow
71
Positive
Cash generation is a relative bright spot: operating cash flow remains strong (~£20.4m in 2025) and free cash flow improved sharply (~£17.1m; +75% growth). Free cash flow materially exceeds reported earnings (free cash flow to net income ~0.84 in 2025 and ~0.46 in 2024), suggesting resilient cash conversion, although the cash flow coverage figure remains below 1.0, indicating cash inflows don’t fully cover all obligations in the metric provided.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue149.09M149.09M161.32M165.66M156.16M119.14M
Gross Profit27.64M27.64M35.52M40.85M36.40M32.90M
EBITDA23.35M23.35M29.21M33.70M30.78M29.67M
Net Income1.89M1.89M7.42M13.22M10.85M7.01M
Balance Sheet
Total Assets90.84M90.84M100.55M98.84M101.57M97.93M
Cash, Cash Equivalents and Short-Term Investments5.95M5.95M3.64M16.35M24.43M19.02M
Total Debt34.60M34.60M34.96M35.29M35.84M47.38M
Total Liabilities54.78M54.78M67.91M65.49M64.33M74.52M
Stockholders Equity36.06M36.06M32.64M33.35M37.24M23.42M
Cash Flow
Free Cash Flow17.66M17.09M9.61M25.56M24.55M27.90M
Operating Cash Flow20.96M20.40M21.11M36.93M29.77M29.30M
Investing Cash Flow-3.31M-3.31M-11.51M-10.89M-1.64M-1.41M
Financing Cash Flow-14.92M-14.92M-22.32M-34.11M-22.20M-22.93M

Shoe Zone Technical Analysis

Technical Analysis Sentiment
Negative
Last Price67.50
Price Trends
50DMA
65.73
Negative
100DMA
69.84
Negative
200DMA
82.78
Negative
Market Momentum
MACD
-3.73
Positive
RSI
15.98
Positive
STOCH
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SHOE, the sentiment is Negative. The current price of 67.5 is above the 20-day moving average (MA) of 58.61, above the 50-day MA of 65.73, and below the 200-day MA of 82.78, indicating a bearish trend. The MACD of -3.73 indicates Positive momentum. The RSI at 15.98 is Positive, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:SHOE.

Shoe Zone Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
£62.51M15.2410.36%15.50%314.96%
68
Neutral
£48.44M8.4612.08%11.65%-3.45%-44.02%
64
Neutral
£62.31M46.303.37%1.76%9.26%31.71%
64
Neutral
£651.96M42.164.61%3.36%-2.59%-46.13%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
54
Neutral
£24.27M12.878.50%-6.24%-82.21%
46
Neutral
£75.07M-8.78-6.53%-22.78%-543.24%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:SHOE
Shoe Zone
52.50
-47.50
-47.50%
GB:G4M
Gear4music (Holdings)
296.00
143.50
94.10%
GB:ULTP
Ultimate Products plc
57.80
-20.93
-26.58%
GB:WJG
Watkin Jones
28.80
-5.80
-16.76%
GB:DOCS
Dr. Martens Plc
65.60
-3.79
-5.46%
GB:LIKE
Likewise Group Plc
24.50
5.55
29.29%

Shoe Zone Corporate Events

Business Operations and StrategyDividendsFinancial Disclosures
Shoe Zone Profits Slide as Tough UK Retail Climate Hits Store Sales but Digital Grows
Negative
Jan 13, 2026

Shoe Zone reported a sharp fall in full-year revenue and profit for the 52 weeks to 27 September 2025, as weak UK consumer confidence, inflationary pressures and higher wage costs hit store trading. Revenue declined 7.6% to £149.1m and profit before tax dropped to £3.3m from £10.1m, with earnings per share sliding to 4.08p and no dividend declared, although net cash rose 64% to £5.9m thanks to reduced capital expenditure and lower stock intake. Store revenues fell as the estate shrank from 297 to 269 sites, but digital sales edged up 2.3% to £36.0m, helped by free next-day delivery and strong marketplace performance, while the group continued to roll out its larger-format stores, secure rent reductions and shorten leases to maintain flexibility. Management remains committed to completing its store refit and relocation programme by 2027, after which it plans to shift more investment towards digital growth, while expecting modest profit before tax in the current year amid persistently challenging trading conditions and ongoing pressure on UK household spending.

The most recent analyst rating on (GB:SHOE) stock is a Hold with a £83.00 price target. To see the full list of analyst forecasts on Shoe Zone stock, see the GB:SHOE Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Shoe Zone Faces Revenue Decline Amid Economic Challenges
Negative
Oct 23, 2025

Shoe Zone’s trading update for the fiscal year ending September 2025 reveals a 7.6% decline in revenue to £149.1 million, attributed to reduced consumer confidence and fewer store locations. Despite a challenging economic environment marked by inflation and higher interest rates, the company improved its net cash position by 66.7% to £6 million. The company closed 39 stores but continues to focus on expanding its larger format stores. Digital revenue saw a slight increase, and the company remains cautious about the near-term outlook, emphasizing prudent cash management and resilience.

The most recent analyst rating on (GB:SHOE) stock is a Hold with a £87.00 price target. To see the full list of analyst forecasts on Shoe Zone stock, see the GB:SHOE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 15, 2026